First Time Loading...

Alnylam Pharmaceuticals Inc
NASDAQ:ALNY

Watchlist Manager
Alnylam Pharmaceuticals Inc Logo
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Watchlist
Price: 150.31 USD 0.23% Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

ALNY Price Targets Summary
Alnylam Pharmaceuticals Inc

Wall Street analysts forecast ALNY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALNY is 226.86 USD with a low forecast of 137.36 USD and a high forecast of 414.75 USD.

Lowest
Price Target
137.36 USD
9% Downside
Average
Price Target
226.86 USD
51% Upside
Highest
Price Target
414.75 USD
176% Upside

ALNY Last Price Targets
Alnylam Pharmaceuticals Inc

The latest public price target was made on Apr 8, 2024 by Kostas Biliouris from BMO Capital , who expects ALNY stock to rise by 56% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Kostas Biliouris
BMO Capital
234 USD
Upside 56%
3 weeks ago
Apr 8, 2024
BMO Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
StreetInsider
Kostas Biliouris
BMO Capital
Price Target 234 USD
Upside/Downside 56%
View Source
Alnylam Pharmaceuticals Inc Competitors:
Price Targets
PHIL
Philogen SpA
34% Upside
300896
Imeik Technology Development Co Ltd
64% Upside
CYTK
Cytokinetics Inc
49% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
236% Upside
KRRO
Korro Bio Inc
128% Upside
BNTX
BioNTech SE
31% Upside
ATORX
Alligator Bioscience AB
147% Upside
UTHR
United Therapeutics Corp
17% Upside

Revenue
Forecast

Revenue Estimate
Alnylam Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Alnylam Pharmaceuticals Inc's revenue is 61%. The projected CAGR for the next 3 years is 21%.

61%
Past Growth
21%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Alnylam Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Alnylam Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALNY's stock price target?
Price Target
226.86 USD

According to Wall Street analysts, the average 1-year price target for ALNY is 226.86 USD with a low forecast of 137.36 USD and a high forecast of 414.75 USD.

What is Alnylam Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Alnylam Pharmaceuticals Inc's revenue is 61%. The projected CAGR for the next 3 years is 21%.